The Company’s technology could provide several products that can be applied to a number of indications. The table below summarizes the Company’s current focus and product pipeline.
| Product | Tmax (Mins) Current Market Leader |
Regulatory Pathway |
Global Market ($B) Size | Indication |
|---|---|---|---|---|
| Transmucosal Nicotine | 15-60 | 505b2 | 1.6 | Smoking Cessation |
| Topical Ibuprofen | NA | 505b2 | 3.0 | Local Pain |